JESSICA ST. JULES: Open Payments
NPI 1255758256 · RIALTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,537 in 72 payments from 10 companies in 2025. Trend: 2023 $1,182 · 2024 $1,021 · 2025 $1,537
Food & beverage: $1,537
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $438 |
| Amgen Inc. | 11 | $366 |
| ABBVIE INC. | 12 | $216 |
| UCB, Inc. | 18 | $143 |
| Novartis Pharmaceuticals Corporation | 4 | $94 |
| LEO Pharma Inc. | 4 | $81 |
| Janssen Biotech, Inc. | 4 | $74 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Arcutis Biotherapeutics, Inc. | 2 | $42 |
| Incyte Corporation | 2 | $36 |
Products named: DUPIXENT, OTEZLA, SKYRIZI, Bimzelx, ADBRY, COSENTYX, TREMFYA, RINVOQ.
Industry payments across CA — which companies pay providers there.
